Transdiagnostic, Indicated Preventive Intervention for Adolescents At High Risk of Emotional Problems W/Add-On Modules
Key facts
- Who runs it
- University of Jaén
- Where
- Spain3 sites in 1 countryChoose a country to see its sites
- Trial code
- Status
- Completed
- People taking part
- 139 people enrolled
- Started
- 15 Mar 2023
- Ended
- 31 Dec 2025
- Type of study
- Interventional, 2 groups
- Treatments tested
- Active control condition
- PROCARE-I+ 8-session
- Record updated
- 1 May 2026
Who can take part
- Age
- 12 years to 18 years
- Sex
- Women and men
- Healthy volunteers
- Can take part
The registry criteria, word for word
Show all 14 criteriaShow less
Who can take part
- written informed consent from adolescent and legal guardian
- able to attend prevention modules on his/her own
- language competence
- Strengths and Difficulties Questionnaire ""probable diagnoses"
- score above cut-off for Revised Child Anxiety and Depression Scale-30
- having incipient symptoms on an emotional level in ADIS 5 C/P
- absence of anxiety and/or mood disorders
Who cannot take part
- concomitant psychological/psychiatric treatment
- have been diagnosed with a neurodevelopmental disorder
- presence of mood and/or anxiety disorders
- in- or outpatient
- acute suicidality
- general medical contraindications that hamper attendance to prevention modules
- Strengths and Difficulties Questionnaire "unlikely" or "possible diagnoses"
This trial has no sites in United States.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
PROCARE is a preventive intervention that has shown its effectiveness in selective prevention to reduce young people's risk of developing emotional problems. In this study, an uncontrolled pre-post study is carried out where this personalized transdiagnostic preventive intervention in online mode is applied in the indicated population, with the following objectives: 1) provide data about whether there are improvements in the emotional state of adolescents after implementing PROCARE-I+; and 2) evaluate if there is any risk factor that predicts anxiety-depressive symptoms and/or emotional difficulties. The sample was made up of 30 adolescents who showed symptoms of anxiety and/or depression and a high risk of developing an emotional disorder and who benefited from the preventive, transdiagnostic, online and personalized intervention called PROCARE-I+. After the analysis of the data collected at the pre-intervention and post-intervention time, the data revealed that the intervention had an impact on improving the emotional state of the adolescents in terms of anxious-depressive symptomatology, quality of life and emotional regulation. On the other hand, the data revealed the absence of predictive relationships between the presence of a risk factor and suffering from symptoms of anxiety and depression; In contrast, predictive relationships were found between the presence of the family risk factor and suffering from some emotional difficulty.
The 2 groups in the trial
- PROCARE-I (UP-A for indicated purposes)Treatment being tested
To ensure cost-effectiveness, PROCARE-I intervention will be designed as a brief 8-session child-focused programme by adapting the core modules from UP-A, along with one individual session with adolescent and parents. Sessions will be delivered in reduced groups, using a typical indicated preventive intervention format focused on cost-effectiveness.
Treatment: Active control condition
- PROCARE-I+ 8-session (for indicated purposes)Treatment being tested
PROCARE-I+ intervention will be designed as a brief 8-session with 4 additonal sessions (add-on modules) child-focused programme by adapting the core modules from UP-A. Sessions will be delivered in reduced groups, using a typical indicated preventive intervention format focused on cost-effectiveness.
Treatment: PROCARE-I+ 8-session
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Official title
- Transdiagnostic, Indicated Preventive Intervention for Adolescents At High Risk of Emotional Problems With Add-On Modules (PROCARE-I+)
- Record updated
- 1 May 2026